nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—hypertension—type 2 diabetes mellitus	0.279	1	CtDrD
Carvedilol—VEGFA—Gliclazide—type 2 diabetes mellitus	0.0806	0.317	CbGbCtD
Carvedilol—GJA1—type 2 diabetes mellitus	0.0723	0.244	CbGaD
Carvedilol—NPPB—type 2 diabetes mellitus	0.0723	0.244	CbGaD
Carvedilol—HIF1A—type 2 diabetes mellitus	0.0548	0.185	CbGaD
Carvedilol—NDUFC2—Metformin—type 2 diabetes mellitus	0.037	0.145	CbGbCtD
Carvedilol—ADRB3—type 2 diabetes mellitus	0.0327	0.11	CbGaD
Carvedilol—VEGFA—type 2 diabetes mellitus	0.0221	0.0744	CbGaD
Carvedilol—ADRA2A—type 2 diabetes mellitus	0.0148	0.0498	CbGaD
Carvedilol—CYP2E1—type 2 diabetes mellitus	0.0108	0.0364	CbGaD
Carvedilol—CYP1A2—type 2 diabetes mellitus	0.0103	0.0346	CbGaD
Carvedilol—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.00761	0.0299	CbGbCtD
Carvedilol—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.00691	0.0272	CbGbCtD
Carvedilol—CYP3A4—type 2 diabetes mellitus	0.0068	0.0229	CbGaD
Carvedilol—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.00656	0.0258	CbGbCtD
Carvedilol—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.006	0.0236	CbGbCtD
Carvedilol—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.006	0.0236	CbGbCtD
Carvedilol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.00596	0.0234	CbGbCtD
Carvedilol—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.00554	0.0218	CbGbCtD
Carvedilol—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.00554	0.0218	CbGbCtD
Carvedilol—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.00456	0.0179	CbGbCtD
Carvedilol—PTGS1—Nateglinide—type 2 diabetes mellitus	0.00455	0.0179	CbGbCtD
Carvedilol—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.00437	0.0172	CbGbCtD
Carvedilol—PTGS1—Irbesartan—type 2 diabetes mellitus	0.00436	0.0171	CbGbCtD
Carvedilol—GJA1—corneal epithelium—type 2 diabetes mellitus	0.00391	0.112	CbGeAlD
Carvedilol—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00364	0.0143	CbGbCtD
Carvedilol—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00334	0.0131	CbGbCtD
Carvedilol—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00324	0.0127	CbGbCtD
Carvedilol—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00305	0.012	CbGbCtD
Carvedilol—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00284	0.0112	CbGbCtD
Carvedilol—VCAM1—tunica intima—type 2 diabetes mellitus	0.00265	0.0758	CbGeAlD
Carvedilol—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00247	0.00972	CbGbCtD
Carvedilol—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00241	0.00949	CbGbCtD
Carvedilol—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00241	0.00949	CbGbCtD
Carvedilol—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00234	0.00921	CbGbCtD
Carvedilol—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00223	0.00876	CbGbCtD
Carvedilol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00221	0.00868	CbGbCtD
Carvedilol—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00218	0.00856	CbGbCtD
Carvedilol—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00215	0.00846	CbGbCtD
Carvedilol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00204	0.00801	CbGbCtD
Carvedilol—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00197	0.00774	CbGbCtD
Carvedilol—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00195	0.00765	CbGbCtD
Carvedilol—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00194	0.00763	CbGbCtD
Carvedilol—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00184	0.00724	CbGbCtD
Carvedilol—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00183	0.00719	CbGbCtD
Carvedilol—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00178	0.00698	CbGbCtD
Carvedilol—ADRB3—brown adipose tissue—type 2 diabetes mellitus	0.00176	0.0504	CbGeAlD
Carvedilol—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00175	0.0069	CbGbCtD
Carvedilol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00167	0.00658	CbGbCtD
Carvedilol—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00161	0.00633	CbGbCtD
Carvedilol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0016	0.00631	CbGbCtD
Carvedilol—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00155	0.0061	CbGbCtD
Carvedilol—NPPB—artery—type 2 diabetes mellitus	0.00146	0.0418	CbGeAlD
Carvedilol—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0014	0.00552	CbGbCtD
Carvedilol—CYP1A2—Losartan—type 2 diabetes mellitus	0.00125	0.00493	CbGbCtD
Carvedilol—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00124	0.00486	CbGbCtD
Carvedilol—ABCB1—Glyburide—type 2 diabetes mellitus	0.0012	0.00472	CbGbCtD
Carvedilol—CYP2C9—Losartan—type 2 diabetes mellitus	0.00113	0.00444	CbGbCtD
Carvedilol—ABCB1—Losartan—type 2 diabetes mellitus	0.0011	0.00431	CbGbCtD
Carvedilol—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00106	0.00418	CbGbCtD
Carvedilol—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00102	0.00401	CbGbCtD
Carvedilol—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00102	0.00401	CbGbCtD
Carvedilol—SELE—artery—type 2 diabetes mellitus	0.000985	0.0282	CbGeAlD
Carvedilol—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.000965	0.00379	CbGbCtD
Carvedilol—VCAM1—artery—type 2 diabetes mellitus	0.000906	0.026	CbGeAlD
Carvedilol—HIF1A—artery—type 2 diabetes mellitus	0.000872	0.025	CbGeAlD
Carvedilol—HIF1A—nerve—type 2 diabetes mellitus	0.000865	0.0248	CbGeAlD
Carvedilol—GJA1—artery—type 2 diabetes mellitus	0.000845	0.0242	CbGeAlD
Carvedilol—SELE—endothelium—type 2 diabetes mellitus	0.000832	0.0238	CbGeAlD
Carvedilol—VCAM1—endothelium—type 2 diabetes mellitus	0.000765	0.0219	CbGeAlD
Carvedilol—HIF1A—endothelium—type 2 diabetes mellitus	0.000736	0.0211	CbGeAlD
Carvedilol—CYP3A4—Glyburide—type 2 diabetes mellitus	0.000719	0.00283	CbGbCtD
Carvedilol—GJA1—endothelium—type 2 diabetes mellitus	0.000714	0.0205	CbGeAlD
Carvedilol—CYP3A4—Losartan—type 2 diabetes mellitus	0.000657	0.00258	CbGbCtD
Carvedilol—NPPB—cardiovascular system—type 2 diabetes mellitus	0.000507	0.0145	CbGeAlD
Carvedilol—NPPB—pancreas—type 2 diabetes mellitus	0.000492	0.0141	CbGeAlD
Carvedilol—VCAM1—islet of Langerhans—type 2 diabetes mellitus	0.000435	0.0125	CbGeAlD
Carvedilol—HIF1A—islet of Langerhans—type 2 diabetes mellitus	0.000419	0.012	CbGeAlD
Carvedilol—Bopindolol—ADRB3—type 2 diabetes mellitus	0.000407	0.37	CrCbGaD
Carvedilol—GJA1—islet of Langerhans—type 2 diabetes mellitus	0.000406	0.0116	CbGeAlD
Carvedilol—SELE—nephron tubule—type 2 diabetes mellitus	0.000381	0.0109	CbGeAlD
Carvedilol—VCAM1—retina—type 2 diabetes mellitus	0.000372	0.0107	CbGeAlD
Carvedilol—HIF1A—retina—type 2 diabetes mellitus	0.000358	0.0103	CbGeAlD
Carvedilol—VCAM1—nephron tubule—type 2 diabetes mellitus	0.00035	0.01	CbGeAlD
Carvedilol—GJA1—retina—type 2 diabetes mellitus	0.000347	0.00995	CbGeAlD
Carvedilol—SELE—cardiovascular system—type 2 diabetes mellitus	0.000342	0.00981	CbGeAlD
Carvedilol—HIF1A—nephron tubule—type 2 diabetes mellitus	0.000337	0.00966	CbGeAlD
Carvedilol—GJA1—nephron tubule—type 2 diabetes mellitus	0.000327	0.00937	CbGeAlD
Carvedilol—SELE—cortex of kidney—type 2 diabetes mellitus	0.000326	0.00934	CbGeAlD
Carvedilol—VEGFA—islet of Langerhans—type 2 diabetes mellitus	0.000321	0.00919	CbGeAlD
Carvedilol—VCAM1—cardiovascular system—type 2 diabetes mellitus	0.000315	0.00902	CbGeAlD
Carvedilol—VCAM1—kidney—type 2 diabetes mellitus	0.000308	0.00883	CbGeAlD
Carvedilol—GJA1—Methysergide—Bromocriptine—type 2 diabetes mellitus	0.000308	0.174	CbGdCrCtD
Carvedilol—VCAM1—pancreas—type 2 diabetes mellitus	0.000306	0.00877	CbGeAlD
Carvedilol—HIF1A—cardiovascular system—type 2 diabetes mellitus	0.000303	0.00868	CbGeAlD
Carvedilol—NDUFC2—retina—type 2 diabetes mellitus	0.000302	0.00866	CbGeAlD
Carvedilol—SELE—adipose tissue—type 2 diabetes mellitus	0.000302	0.00865	CbGeAlD
Carvedilol—VCAM1—cortex of kidney—type 2 diabetes mellitus	0.0003	0.00859	CbGeAlD
Carvedilol—HIF1A—kidney—type 2 diabetes mellitus	0.000296	0.00849	CbGeAlD
Carvedilol—HIF1A—pancreas—type 2 diabetes mellitus	0.000294	0.00843	CbGeAlD
Carvedilol—GJA1—cardiovascular system—type 2 diabetes mellitus	0.000294	0.00842	CbGeAlD
Carvedilol—HIF1A—cortex of kidney—type 2 diabetes mellitus	0.000289	0.00827	CbGeAlD
Carvedilol—GJA1—kidney—type 2 diabetes mellitus	0.000287	0.00824	CbGeAlD
Carvedilol—GJA1—pancreas—type 2 diabetes mellitus	0.000286	0.00818	CbGeAlD
Carvedilol—GJA1—cortex of kidney—type 2 diabetes mellitus	0.00028	0.00802	CbGeAlD
Carvedilol—VCAM1—adipose tissue—type 2 diabetes mellitus	0.000278	0.00795	CbGeAlD
Carvedilol—HIF1A—adipose tissue—type 2 diabetes mellitus	0.000267	0.00765	CbGeAlD
Carvedilol—GJA1—adipose tissue—type 2 diabetes mellitus	0.000259	0.00742	CbGeAlD
Carvedilol—VEGFA—nephron tubule—type 2 diabetes mellitus	0.000258	0.0074	CbGeAlD
Carvedilol—NDUFC2—cardiovascular system—type 2 diabetes mellitus	0.000256	0.00733	CbGeAlD
Carvedilol—GJA1—Rosiglitazone—Pioglitazone—type 2 diabetes mellitus	0.000251	0.142	CbGdCrCtD
Carvedilol—NDUFC2—kidney—type 2 diabetes mellitus	0.00025	0.00717	CbGeAlD
Carvedilol—NDUFC2—cortex of kidney—type 2 diabetes mellitus	0.000244	0.00698	CbGeAlD
Carvedilol—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000242	0.00694	CbGeAlD
Carvedilol—ADRB3—adipose tissue—type 2 diabetes mellitus	0.000237	0.0068	CbGeAlD
Carvedilol—NDUFC2—adipose tissue—type 2 diabetes mellitus	0.000226	0.00646	CbGeAlD
Carvedilol—VEGFA—pancreas—type 2 diabetes mellitus	0.000225	0.00646	CbGeAlD
Carvedilol—VEGFA—cortex of kidney—type 2 diabetes mellitus	0.000221	0.00633	CbGeAlD
Carvedilol—SELE—liver—type 2 diabetes mellitus	0.000212	0.00606	CbGeAlD
Carvedilol—VEGFA—adipose tissue—type 2 diabetes mellitus	0.000205	0.00586	CbGeAlD
Carvedilol—XDH—kidney—type 2 diabetes mellitus	0.000202	0.00579	CbGeAlD
Carvedilol—VCAM1—liver—type 2 diabetes mellitus	0.000195	0.00558	CbGeAlD
Carvedilol—HIF1A—liver—type 2 diabetes mellitus	0.000187	0.00537	CbGeAlD
Carvedilol—GJA1—liver—type 2 diabetes mellitus	0.000182	0.00521	CbGeAlD
Carvedilol—PTGS1—artery—type 2 diabetes mellitus	0.000179	0.00514	CbGeAlD
Carvedilol—Tamsulosin—ADRA2A—type 2 diabetes mellitus	0.000178	0.161	CrCbGaD
Carvedilol—NDUFC2—liver—type 2 diabetes mellitus	0.000158	0.00453	CbGeAlD
Carvedilol—Propranolol—ADRB3—type 2 diabetes mellitus	0.000153	0.139	CrCbGaD
Carvedilol—PTGS1—endothelium—type 2 diabetes mellitus	0.000152	0.00434	CbGeAlD
Carvedilol—ADRA1B—kidney—type 2 diabetes mellitus	0.000152	0.00434	CbGeAlD
Carvedilol—HIF1A—Glyburide—Glimepiride—type 2 diabetes mellitus	0.00015	0.0848	CbGdCrCtD
Carvedilol—HIF1A—Glyburide—Tolazamide—type 2 diabetes mellitus	0.00015	0.0848	CbGdCrCtD
Carvedilol—VEGFA—liver—type 2 diabetes mellitus	0.000143	0.00411	CbGeAlD
Carvedilol—HIF1A—Glyburide—Gliclazide—type 2 diabetes mellitus	0.000142	0.0804	CbGdCrCtD
Carvedilol—HIF1A—Glyburide—Glipizide—type 2 diabetes mellitus	0.000142	0.0804	CbGdCrCtD
Carvedilol—HIF1A—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.00013	0.0735	CbGdCrCtD
Carvedilol—XDH—liver—type 2 diabetes mellitus	0.000128	0.00366	CbGeAlD
Carvedilol—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000116	0.00333	CbGeAlD
Carvedilol—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.00011	0.00315	CbGeAlD
Carvedilol—ADRB1—adipose tissue—type 2 diabetes mellitus	9.71e-05	0.00278	CbGeAlD
Carvedilol—ADRA2C—nephron tubule—type 2 diabetes mellitus	9.24e-05	0.00265	CbGeAlD
Carvedilol—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	9.15e-05	0.00262	CbGeAlD
Carvedilol—ADRA1A—cardiovascular system—type 2 diabetes mellitus	8.71e-05	0.00249	CbGeAlD
Carvedilol—Ranolazine—CYP3A4—type 2 diabetes mellitus	8.48e-05	0.077	CrCbGaD
Carvedilol—KCNH2—cardiovascular system—type 2 diabetes mellitus	8.41e-05	0.00241	CbGeAlD
Carvedilol—Tamsulosin—CYP3A4—type 2 diabetes mellitus	8.16e-05	0.0742	CrCbGaD
Carvedilol—ADRA2C—kidney—type 2 diabetes mellitus	8.12e-05	0.00233	CbGeAlD
Carvedilol—ADRA2C—pancreas—type 2 diabetes mellitus	8.06e-05	0.00231	CbGeAlD
Carvedilol—ADRA2C—cortex of kidney—type 2 diabetes mellitus	7.9e-05	0.00226	CbGeAlD
Carvedilol—ADRA1A—adipose tissue—type 2 diabetes mellitus	7.68e-05	0.0022	CbGeAlD
Carvedilol—ADRA2C—adipose tissue—type 2 diabetes mellitus	7.31e-05	0.0021	CbGeAlD
Carvedilol—CYP2E1—nephron tubule—type 2 diabetes mellitus	7.21e-05	0.00207	CbGeAlD
Carvedilol—Propafenone—CYP1A2—type 2 diabetes mellitus	7.02e-05	0.0638	CrCbGaD
Carvedilol—CYP1A1—kidney—type 2 diabetes mellitus	6.95e-05	0.00199	CbGeAlD
Carvedilol—VEGFA—Glyburide—Tolazamide—type 2 diabetes mellitus	6.94e-05	0.0393	CbGdCrCtD
Carvedilol—VEGFA—Glyburide—Glimepiride—type 2 diabetes mellitus	6.94e-05	0.0393	CbGdCrCtD
Carvedilol—CYP2C9—cardiovascular system—type 2 diabetes mellitus	6.83e-05	0.00196	CbGeAlD
Carvedilol—VEGFA—Glyburide—Glipizide—type 2 diabetes mellitus	6.58e-05	0.0372	CbGdCrCtD
Carvedilol—VEGFA—Glyburide—Gliclazide—type 2 diabetes mellitus	6.58e-05	0.0372	CbGdCrCtD
Carvedilol—CYP2E1—cardiovascular system—type 2 diabetes mellitus	6.48e-05	0.00186	CbGeAlD
Carvedilol—ADRA2A—pancreas—type 2 diabetes mellitus	6.43e-05	0.00184	CbGeAlD
Carvedilol—CYP2E1—kidney—type 2 diabetes mellitus	6.34e-05	0.00182	CbGeAlD
Carvedilol—ADRA2A—cortex of kidney—type 2 diabetes mellitus	6.31e-05	0.00181	CbGeAlD
Carvedilol—CYP1A1—adipose tissue—type 2 diabetes mellitus	6.26e-05	0.00179	CbGeAlD
Carvedilol—PTGS1—cardiovascular system—type 2 diabetes mellitus	6.24e-05	0.00179	CbGeAlD
Carvedilol—CYP2E1—cortex of kidney—type 2 diabetes mellitus	6.17e-05	0.00177	CbGeAlD
Carvedilol—PTGS1—kidney—type 2 diabetes mellitus	6.1e-05	0.00175	CbGeAlD
Carvedilol—VEGFA—Glyburide—Chlorpropamide—type 2 diabetes mellitus	6.02e-05	0.034	CbGdCrCtD
Carvedilol—ADRA2A—adipose tissue—type 2 diabetes mellitus	5.84e-05	0.00167	CbGeAlD
Carvedilol—PTGS1—adipose tissue—type 2 diabetes mellitus	5.5e-05	0.00158	CbGeAlD
Carvedilol—GJA1—Enalapril—Nateglinide—type 2 diabetes mellitus	5.44e-05	0.0308	CbGdCrCtD
Carvedilol—ADRA1A—liver—type 2 diabetes mellitus	5.38e-05	0.00154	CbGeAlD
Carvedilol—ADRA2C—liver—type 2 diabetes mellitus	5.13e-05	0.00147	CbGeAlD
Carvedilol—ABCB1—islet of Langerhans—type 2 diabetes mellitus	5.1e-05	0.00146	CbGeAlD
Carvedilol—CYP3A4—kidney—type 2 diabetes mellitus	5.1e-05	0.00146	CbGeAlD
Carvedilol—CYP2D6—kidney—type 2 diabetes mellitus	5.02e-05	0.00144	CbGeAlD
Carvedilol—Propranolol—CYP1A2—type 2 diabetes mellitus	4.81e-05	0.0437	CrCbGaD
Carvedilol—VEGFA—Enalapril—Nateglinide—type 2 diabetes mellitus	4.8e-05	0.0271	CbGdCrCtD
Carvedilol—Propafenone—CYP3A4—type 2 diabetes mellitus	4.65e-05	0.0422	CrCbGaD
Carvedilol—CYP1A2—liver—type 2 diabetes mellitus	4.45e-05	0.00128	CbGeAlD
Carvedilol—CYP1A1—liver—type 2 diabetes mellitus	4.39e-05	0.00126	CbGeAlD
Carvedilol—ABCB1—retina—type 2 diabetes mellitus	4.36e-05	0.00125	CbGeAlD
Carvedilol—CYP2C9—liver—type 2 diabetes mellitus	4.23e-05	0.00121	CbGeAlD
Carvedilol—ABCB1—nephron tubule—type 2 diabetes mellitus	4.11e-05	0.00118	CbGeAlD
Carvedilol—CYP2E1—liver—type 2 diabetes mellitus	4e-05	0.00115	CbGeAlD
Carvedilol—ABCB1—cardiovascular system—type 2 diabetes mellitus	3.69e-05	0.00106	CbGeAlD
Carvedilol—ABCB1—kidney—type 2 diabetes mellitus	3.61e-05	0.00103	CbGeAlD
Carvedilol—ABCB1—pancreas—type 2 diabetes mellitus	3.58e-05	0.00103	CbGeAlD
Carvedilol—ABCB1—cortex of kidney—type 2 diabetes mellitus	3.51e-05	0.00101	CbGeAlD
Carvedilol—GJA1—Enalapril—Ramipril—type 2 diabetes mellitus	3.31e-05	0.0187	CbGdCrCtD
Carvedilol—ABCB1—adipose tissue—type 2 diabetes mellitus	3.25e-05	0.000932	CbGeAlD
Carvedilol—CYP3A4—liver—type 2 diabetes mellitus	3.22e-05	0.000923	CbGeAlD
Carvedilol—Propranolol—CYP3A4—type 2 diabetes mellitus	3.18e-05	0.0289	CrCbGaD
Carvedilol—CYP2D6—liver—type 2 diabetes mellitus	3.17e-05	0.000908	CbGeAlD
Carvedilol—VEGFA—Enalapril—Ramipril—type 2 diabetes mellitus	2.92e-05	0.0165	CbGdCrCtD
Carvedilol—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	2.63e-05	0.000356	CcSEcCtD
Carvedilol—Paraesthesia—Valsartan—type 2 diabetes mellitus	2.62e-05	0.000355	CcSEcCtD
Carvedilol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	2.62e-05	0.000355	CcSEcCtD
Carvedilol—Myalgia—Irbesartan—type 2 diabetes mellitus	2.62e-05	0.000355	CcSEcCtD
Carvedilol—Arthralgia—Irbesartan—type 2 diabetes mellitus	2.62e-05	0.000355	CcSEcCtD
Carvedilol—Chest pain—Irbesartan—type 2 diabetes mellitus	2.62e-05	0.000355	CcSEcCtD
Carvedilol—Shock—Metformin—type 2 diabetes mellitus	2.62e-05	0.000354	CcSEcCtD
Carvedilol—Insomnia—Orlistat—type 2 diabetes mellitus	2.61e-05	0.000354	CcSEcCtD
Carvedilol—Malaise—Losartan—type 2 diabetes mellitus	2.61e-05	0.000354	CcSEcCtD
Carvedilol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	2.61e-05	0.000353	CcSEcCtD
Carvedilol—Thrombocytopenia—Metformin—type 2 diabetes mellitus	2.6e-05	0.000353	CcSEcCtD
Carvedilol—Dyspnoea—Valsartan—type 2 diabetes mellitus	2.6e-05	0.000353	CcSEcCtD
Carvedilol—Vertigo—Losartan—type 2 diabetes mellitus	2.6e-05	0.000352	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	2.6e-05	0.000352	CcSEcCtD
Carvedilol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	2.6e-05	0.000352	CcSEcCtD
Carvedilol—Somnolence—Valsartan—type 2 diabetes mellitus	2.6e-05	0.000352	CcSEcCtD
Carvedilol—Syncope—Losartan—type 2 diabetes mellitus	2.6e-05	0.000352	CcSEcCtD
Carvedilol—Paraesthesia—Orlistat—type 2 diabetes mellitus	2.59e-05	0.000351	CcSEcCtD
Carvedilol—Leukopenia—Losartan—type 2 diabetes mellitus	2.59e-05	0.000351	CcSEcCtD
Carvedilol—Discomfort—Irbesartan—type 2 diabetes mellitus	2.59e-05	0.00035	CcSEcCtD
Carvedilol—Skin disorder—Metformin—type 2 diabetes mellitus	2.58e-05	0.00035	CcSEcCtD
Carvedilol—Immune system disorder—Ramipril—type 2 diabetes mellitus	2.57e-05	0.000349	CcSEcCtD
Carvedilol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	2.57e-05	0.000348	CcSEcCtD
Carvedilol—Dyspepsia—Valsartan—type 2 diabetes mellitus	2.57e-05	0.000348	CcSEcCtD
Carvedilol—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	2.57e-05	0.000348	CcSEcCtD
Carvedilol—Dizziness—Bromocriptine—type 2 diabetes mellitus	2.56e-05	0.000347	CcSEcCtD
Carvedilol—Dry mouth—Irbesartan—type 2 diabetes mellitus	2.56e-05	0.000347	CcSEcCtD
Carvedilol—Palpitations—Losartan—type 2 diabetes mellitus	2.56e-05	0.000346	CcSEcCtD
Carvedilol—Nausea—Glimepiride—type 2 diabetes mellitus	2.55e-05	0.000345	CcSEcCtD
Carvedilol—Loss of consciousness—Losartan—type 2 diabetes mellitus	2.54e-05	0.000345	CcSEcCtD
Carvedilol—Nausea—Sitagliptin—type 2 diabetes mellitus	2.54e-05	0.000344	CcSEcCtD
Carvedilol—Dyspepsia—Orlistat—type 2 diabetes mellitus	2.54e-05	0.000344	CcSEcCtD
Carvedilol—Asthenia—Glyburide—type 2 diabetes mellitus	2.54e-05	0.000344	CcSEcCtD
Carvedilol—Decreased appetite—Valsartan—type 2 diabetes mellitus	2.54e-05	0.000344	CcSEcCtD
Carvedilol—Anorexia—Metformin—type 2 diabetes mellitus	2.53e-05	0.000343	CcSEcCtD
Carvedilol—Cough—Losartan—type 2 diabetes mellitus	2.53e-05	0.000342	CcSEcCtD
Carvedilol—Urticaria—Gliclazide—type 2 diabetes mellitus	2.52e-05	0.000342	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	2.52e-05	0.000342	CcSEcCtD
Carvedilol—Alopecia—Ramipril—type 2 diabetes mellitus	2.52e-05	0.000341	CcSEcCtD
Carvedilol—Fatigue—Valsartan—type 2 diabetes mellitus	2.52e-05	0.000341	CcSEcCtD
Carvedilol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	2.51e-05	0.00034	CcSEcCtD
Carvedilol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	2.51e-05	0.00034	CcSEcCtD
Carvedilol—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	2.51e-05	0.00034	CcSEcCtD
Carvedilol—Oedema—Irbesartan—type 2 diabetes mellitus	2.51e-05	0.00034	CcSEcCtD
Carvedilol—Decreased appetite—Orlistat—type 2 diabetes mellitus	2.51e-05	0.00034	CcSEcCtD
Carvedilol—Pruritus—Glyburide—type 2 diabetes mellitus	2.5e-05	0.000339	CcSEcCtD
Carvedilol—Constipation—Valsartan—type 2 diabetes mellitus	2.5e-05	0.000338	CcSEcCtD
Carvedilol—Infection—Irbesartan—type 2 diabetes mellitus	2.49e-05	0.000338	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	2.49e-05	0.000337	CcSEcCtD
Carvedilol—Fatigue—Orlistat—type 2 diabetes mellitus	2.49e-05	0.000337	CcSEcCtD
Carvedilol—Hypotension—Metformin—type 2 diabetes mellitus	2.48e-05	0.000337	CcSEcCtD
Carvedilol—Malnutrition—Ramipril—type 2 diabetes mellitus	2.48e-05	0.000336	CcSEcCtD
Carvedilol—Shock—Irbesartan—type 2 diabetes mellitus	2.47e-05	0.000334	CcSEcCtD
Carvedilol—Pain—Orlistat—type 2 diabetes mellitus	2.47e-05	0.000334	CcSEcCtD
Carvedilol—Chest pain—Losartan—type 2 diabetes mellitus	2.46e-05	0.000334	CcSEcCtD
Carvedilol—Arthralgia—Losartan—type 2 diabetes mellitus	2.46e-05	0.000334	CcSEcCtD
Carvedilol—Myalgia—Losartan—type 2 diabetes mellitus	2.46e-05	0.000334	CcSEcCtD
Carvedilol—Vomiting—Bromocriptine—type 2 diabetes mellitus	2.46e-05	0.000334	CcSEcCtD
Carvedilol—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	2.46e-05	0.000333	CcSEcCtD
Carvedilol—Tachycardia—Irbesartan—type 2 diabetes mellitus	2.45e-05	0.000332	CcSEcCtD
Carvedilol—Rash—Bromocriptine—type 2 diabetes mellitus	2.44e-05	0.000331	CcSEcCtD
Carvedilol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	2.44e-05	0.00033	CcSEcCtD
Carvedilol—Skin disorder—Irbesartan—type 2 diabetes mellitus	2.44e-05	0.00033	CcSEcCtD
Carvedilol—Tension—Ramipril—type 2 diabetes mellitus	2.43e-05	0.00033	CcSEcCtD
Carvedilol—Discomfort—Losartan—type 2 diabetes mellitus	2.43e-05	0.00033	CcSEcCtD
Carvedilol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	2.43e-05	0.000329	CcSEcCtD
Carvedilol—Headache—Bromocriptine—type 2 diabetes mellitus	2.43e-05	0.000329	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	2.42e-05	0.000328	CcSEcCtD
Carvedilol—Diarrhoea—Glyburide—type 2 diabetes mellitus	2.42e-05	0.000328	CcSEcCtD
Carvedilol—Nervousness—Ramipril—type 2 diabetes mellitus	2.41e-05	0.000326	CcSEcCtD
Carvedilol—Dry mouth—Losartan—type 2 diabetes mellitus	2.41e-05	0.000326	CcSEcCtD
Carvedilol—Anorexia—Irbesartan—type 2 diabetes mellitus	2.39e-05	0.000324	CcSEcCtD
Carvedilol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	2.39e-05	0.000323	CcSEcCtD
Carvedilol—Paraesthesia—Metformin—type 2 diabetes mellitus	2.39e-05	0.000323	CcSEcCtD
Carvedilol—Muscle spasms—Ramipril—type 2 diabetes mellitus	2.39e-05	0.000323	CcSEcCtD
Carvedilol—Confusional state—Losartan—type 2 diabetes mellitus	2.38e-05	0.000323	CcSEcCtD
Carvedilol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	2.38e-05	0.000322	CcSEcCtD
Carvedilol—Dyspnoea—Metformin—type 2 diabetes mellitus	2.37e-05	0.000321	CcSEcCtD
Carvedilol—Somnolence—Metformin—type 2 diabetes mellitus	2.36e-05	0.00032	CcSEcCtD
Carvedilol—Anaphylactic shock—Losartan—type 2 diabetes mellitus	2.36e-05	0.00032	CcSEcCtD
Carvedilol—Oedema—Losartan—type 2 diabetes mellitus	2.36e-05	0.00032	CcSEcCtD
Carvedilol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	2.36e-05	0.00032	CcSEcCtD
Carvedilol—Infection—Losartan—type 2 diabetes mellitus	2.35e-05	0.000318	CcSEcCtD
Carvedilol—Hypotension—Irbesartan—type 2 diabetes mellitus	2.34e-05	0.000318	CcSEcCtD
Carvedilol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	2.34e-05	0.000317	CcSEcCtD
Carvedilol—Dyspepsia—Metformin—type 2 diabetes mellitus	2.34e-05	0.000317	CcSEcCtD
Carvedilol—Shock—Losartan—type 2 diabetes mellitus	2.32e-05	0.000315	CcSEcCtD
Carvedilol—Urticaria—Valsartan—type 2 diabetes mellitus	2.32e-05	0.000314	CcSEcCtD
Carvedilol—Thrombocytopenia—Losartan—type 2 diabetes mellitus	2.31e-05	0.000313	CcSEcCtD
Carvedilol—Decreased appetite—Metformin—type 2 diabetes mellitus	2.31e-05	0.000313	CcSEcCtD
Carvedilol—Abdominal pain—Valsartan—type 2 diabetes mellitus	2.31e-05	0.000313	CcSEcCtD
Carvedilol—Tachycardia—Losartan—type 2 diabetes mellitus	2.3e-05	0.000312	CcSEcCtD
Carvedilol—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	2.3e-05	0.000312	CcSEcCtD
Carvedilol—Nausea—Bromocriptine—type 2 diabetes mellitus	2.3e-05	0.000312	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	2.3e-05	0.000311	CcSEcCtD
Carvedilol—Fatigue—Metformin—type 2 diabetes mellitus	2.29e-05	0.000311	CcSEcCtD
Carvedilol—Urticaria—Orlistat—type 2 diabetes mellitus	2.29e-05	0.000311	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	2.29e-05	0.00031	CcSEcCtD
Carvedilol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	2.28e-05	0.000309	CcSEcCtD
Carvedilol—Body temperature increased—Orlistat—type 2 diabetes mellitus	2.28e-05	0.000309	CcSEcCtD
Carvedilol—Abdominal pain—Orlistat—type 2 diabetes mellitus	2.28e-05	0.000309	CcSEcCtD
Carvedilol—ABCB1—liver—type 2 diabetes mellitus	2.28e-05	0.000653	CbGeAlD
Carvedilol—Asthenia—Gliclazide—type 2 diabetes mellitus	2.28e-05	0.000309	CcSEcCtD
Carvedilol—Constipation—Metformin—type 2 diabetes mellitus	2.27e-05	0.000308	CcSEcCtD
Carvedilol—Angioedema—Ramipril—type 2 diabetes mellitus	2.27e-05	0.000307	CcSEcCtD
Carvedilol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	2.25e-05	0.000305	CcSEcCtD
Carvedilol—Anorexia—Losartan—type 2 diabetes mellitus	2.25e-05	0.000305	CcSEcCtD
Carvedilol—Vomiting—Glyburide—type 2 diabetes mellitus	2.25e-05	0.000305	CcSEcCtD
Carvedilol—Pruritus—Gliclazide—type 2 diabetes mellitus	2.25e-05	0.000305	CcSEcCtD
Carvedilol—Malaise—Ramipril—type 2 diabetes mellitus	2.24e-05	0.000303	CcSEcCtD
Carvedilol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	2.24e-05	0.000303	CcSEcCtD
Carvedilol—Rash—Glyburide—type 2 diabetes mellitus	2.23e-05	0.000302	CcSEcCtD
Carvedilol—Somnolence—Irbesartan—type 2 diabetes mellitus	2.23e-05	0.000302	CcSEcCtD
Carvedilol—Dermatitis—Glyburide—type 2 diabetes mellitus	2.23e-05	0.000302	CcSEcCtD
Carvedilol—Vertigo—Ramipril—type 2 diabetes mellitus	2.23e-05	0.000302	CcSEcCtD
Carvedilol—Syncope—Ramipril—type 2 diabetes mellitus	2.23e-05	0.000301	CcSEcCtD
Carvedilol—Leukopenia—Ramipril—type 2 diabetes mellitus	2.22e-05	0.000301	CcSEcCtD
Carvedilol—Headache—Glyburide—type 2 diabetes mellitus	2.22e-05	0.0003	CcSEcCtD
Carvedilol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	2.21e-05	0.000299	CcSEcCtD
Carvedilol—Hypotension—Losartan—type 2 diabetes mellitus	2.21e-05	0.000299	CcSEcCtD
Carvedilol—Palpitations—Ramipril—type 2 diabetes mellitus	2.19e-05	0.000297	CcSEcCtD
Carvedilol—Feeling abnormal—Metformin—type 2 diabetes mellitus	2.19e-05	0.000297	CcSEcCtD
Carvedilol—Decreased appetite—Irbesartan—type 2 diabetes mellitus	2.18e-05	0.000296	CcSEcCtD
Carvedilol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	2.18e-05	0.000295	CcSEcCtD
Carvedilol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	2.17e-05	0.000295	CcSEcCtD
Carvedilol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	2.17e-05	0.000295	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	2.17e-05	0.000294	CcSEcCtD
Carvedilol—Cough—Ramipril—type 2 diabetes mellitus	2.17e-05	0.000293	CcSEcCtD
Carvedilol—Fatigue—Irbesartan—type 2 diabetes mellitus	2.16e-05	0.000293	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	2.15e-05	0.000291	CcSEcCtD
Carvedilol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	2.15e-05	0.000291	CcSEcCtD
Carvedilol—Convulsion—Ramipril—type 2 diabetes mellitus	2.15e-05	0.000291	CcSEcCtD
Carvedilol—Constipation—Irbesartan—type 2 diabetes mellitus	2.15e-05	0.000291	CcSEcCtD
Carvedilol—Pain—Irbesartan—type 2 diabetes mellitus	2.15e-05	0.000291	CcSEcCtD
Carvedilol—Insomnia—Losartan—type 2 diabetes mellitus	2.14e-05	0.000289	CcSEcCtD
Carvedilol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	2.13e-05	0.000288	CcSEcCtD
Carvedilol—Paraesthesia—Losartan—type 2 diabetes mellitus	2.12e-05	0.000287	CcSEcCtD
Carvedilol—Urticaria—Metformin—type 2 diabetes mellitus	2.11e-05	0.000286	CcSEcCtD
Carvedilol—Chest pain—Ramipril—type 2 diabetes mellitus	2.11e-05	0.000286	CcSEcCtD
Carvedilol—Arthralgia—Ramipril—type 2 diabetes mellitus	2.11e-05	0.000286	CcSEcCtD
Carvedilol—Myalgia—Ramipril—type 2 diabetes mellitus	2.11e-05	0.000286	CcSEcCtD
Carvedilol—Dyspnoea—Losartan—type 2 diabetes mellitus	2.11e-05	0.000285	CcSEcCtD
Carvedilol—Nausea—Glyburide—type 2 diabetes mellitus	2.1e-05	0.000285	CcSEcCtD
Carvedilol—Abdominal pain—Metformin—type 2 diabetes mellitus	2.1e-05	0.000285	CcSEcCtD
Carvedilol—Dizziness—Gliclazide—type 2 diabetes mellitus	2.1e-05	0.000285	CcSEcCtD
Carvedilol—Somnolence—Losartan—type 2 diabetes mellitus	2.1e-05	0.000284	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	2.1e-05	0.000284	CcSEcCtD
Carvedilol—Asthenia—Valsartan—type 2 diabetes mellitus	2.1e-05	0.000284	CcSEcCtD
Carvedilol—Discomfort—Ramipril—type 2 diabetes mellitus	2.09e-05	0.000283	CcSEcCtD
Carvedilol—Dyspepsia—Losartan—type 2 diabetes mellitus	2.08e-05	0.000282	CcSEcCtD
Carvedilol—Asthenia—Orlistat—type 2 diabetes mellitus	2.07e-05	0.00028	CcSEcCtD
Carvedilol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	2.07e-05	0.00028	CcSEcCtD
Carvedilol—Pruritus—Valsartan—type 2 diabetes mellitus	2.07e-05	0.00028	CcSEcCtD
Carvedilol—Dry mouth—Ramipril—type 2 diabetes mellitus	2.07e-05	0.00028	CcSEcCtD
Carvedilol—Decreased appetite—Losartan—type 2 diabetes mellitus	2.05e-05	0.000278	CcSEcCtD
Carvedilol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	2.05e-05	0.000278	CcSEcCtD
Carvedilol—Confusional state—Ramipril—type 2 diabetes mellitus	2.04e-05	0.000277	CcSEcCtD
Carvedilol—Pruritus—Orlistat—type 2 diabetes mellitus	2.04e-05	0.000277	CcSEcCtD
Carvedilol—Fatigue—Losartan—type 2 diabetes mellitus	2.04e-05	0.000276	CcSEcCtD
Carvedilol—Oedema—Ramipril—type 2 diabetes mellitus	2.03e-05	0.000274	CcSEcCtD
Carvedilol—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	2.03e-05	0.000274	CcSEcCtD
Carvedilol—Vomiting—Gliclazide—type 2 diabetes mellitus	2.02e-05	0.000274	CcSEcCtD
Carvedilol—Pain—Losartan—type 2 diabetes mellitus	2.02e-05	0.000274	CcSEcCtD
Carvedilol—Constipation—Losartan—type 2 diabetes mellitus	2.02e-05	0.000274	CcSEcCtD
Carvedilol—Rash—Gliclazide—type 2 diabetes mellitus	2e-05	0.000271	CcSEcCtD
Carvedilol—Dermatitis—Gliclazide—type 2 diabetes mellitus	2e-05	0.000271	CcSEcCtD
Carvedilol—Diarrhoea—Valsartan—type 2 diabetes mellitus	2e-05	0.000271	CcSEcCtD
Carvedilol—Urticaria—Irbesartan—type 2 diabetes mellitus	1.99e-05	0.00027	CcSEcCtD
Carvedilol—Shock—Ramipril—type 2 diabetes mellitus	1.99e-05	0.00027	CcSEcCtD
Carvedilol—Headache—Gliclazide—type 2 diabetes mellitus	1.99e-05	0.00027	CcSEcCtD
Carvedilol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	1.98e-05	0.000269	CcSEcCtD
Carvedilol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	1.98e-05	0.000269	CcSEcCtD
Carvedilol—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	1.98e-05	0.000269	CcSEcCtD
Carvedilol—Tachycardia—Ramipril—type 2 diabetes mellitus	1.98e-05	0.000268	CcSEcCtD
Carvedilol—Diarrhoea—Orlistat—type 2 diabetes mellitus	1.97e-05	0.000267	CcSEcCtD
Carvedilol—Skin disorder—Ramipril—type 2 diabetes mellitus	1.97e-05	0.000266	CcSEcCtD
Carvedilol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	1.96e-05	0.000265	CcSEcCtD
Carvedilol—Feeling abnormal—Losartan—type 2 diabetes mellitus	1.95e-05	0.000264	CcSEcCtD
Carvedilol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	1.93e-05	0.000262	CcSEcCtD
Carvedilol—Dizziness—Valsartan—type 2 diabetes mellitus	1.93e-05	0.000262	CcSEcCtD
Carvedilol—Anorexia—Ramipril—type 2 diabetes mellitus	1.93e-05	0.000262	CcSEcCtD
Carvedilol—Dizziness—Orlistat—type 2 diabetes mellitus	1.91e-05	0.000258	CcSEcCtD
Carvedilol—Asthenia—Metformin—type 2 diabetes mellitus	1.91e-05	0.000258	CcSEcCtD
Carvedilol—Hypotension—Ramipril—type 2 diabetes mellitus	1.89e-05	0.000256	CcSEcCtD
Carvedilol—Nausea—Gliclazide—type 2 diabetes mellitus	1.89e-05	0.000256	CcSEcCtD
Carvedilol—Pruritus—Metformin—type 2 diabetes mellitus	1.88e-05	0.000255	CcSEcCtD
Carvedilol—Urticaria—Losartan—type 2 diabetes mellitus	1.88e-05	0.000254	CcSEcCtD
Carvedilol—Abdominal pain—Losartan—type 2 diabetes mellitus	1.87e-05	0.000253	CcSEcCtD
Carvedilol—Body temperature increased—Losartan—type 2 diabetes mellitus	1.87e-05	0.000253	CcSEcCtD
Carvedilol—Vomiting—Valsartan—type 2 diabetes mellitus	1.86e-05	0.000252	CcSEcCtD
Carvedilol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	1.85e-05	0.00025	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	1.85e-05	0.00025	CcSEcCtD
Carvedilol—Rash—Valsartan—type 2 diabetes mellitus	1.84e-05	0.000249	CcSEcCtD
Carvedilol—Dermatitis—Valsartan—type 2 diabetes mellitus	1.84e-05	0.000249	CcSEcCtD
Carvedilol—Vomiting—Orlistat—type 2 diabetes mellitus	1.83e-05	0.000249	CcSEcCtD
Carvedilol—Insomnia—Ramipril—type 2 diabetes mellitus	1.83e-05	0.000248	CcSEcCtD
Carvedilol—Headache—Valsartan—type 2 diabetes mellitus	1.83e-05	0.000248	CcSEcCtD
Carvedilol—Diarrhoea—Metformin—type 2 diabetes mellitus	1.82e-05	0.000246	CcSEcCtD
Carvedilol—Rash—Orlistat—type 2 diabetes mellitus	1.82e-05	0.000246	CcSEcCtD
Carvedilol—Paraesthesia—Ramipril—type 2 diabetes mellitus	1.82e-05	0.000246	CcSEcCtD
Carvedilol—Dermatitis—Orlistat—type 2 diabetes mellitus	1.82e-05	0.000246	CcSEcCtD
Carvedilol—Headache—Orlistat—type 2 diabetes mellitus	1.81e-05	0.000245	CcSEcCtD
Carvedilol—Dyspnoea—Ramipril—type 2 diabetes mellitus	1.81e-05	0.000245	CcSEcCtD
Carvedilol—Asthenia—Irbesartan—type 2 diabetes mellitus	1.8e-05	0.000244	CcSEcCtD
Carvedilol—Somnolence—Ramipril—type 2 diabetes mellitus	1.8e-05	0.000244	CcSEcCtD
Carvedilol—Dyspepsia—Ramipril—type 2 diabetes mellitus	1.78e-05	0.000241	CcSEcCtD
Carvedilol—Pruritus—Irbesartan—type 2 diabetes mellitus	1.78e-05	0.000241	CcSEcCtD
Carvedilol—Decreased appetite—Ramipril—type 2 diabetes mellitus	1.76e-05	0.000238	CcSEcCtD
Carvedilol—Dizziness—Metformin—type 2 diabetes mellitus	1.76e-05	0.000238	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	1.75e-05	0.000237	CcSEcCtD
Carvedilol—Fatigue—Ramipril—type 2 diabetes mellitus	1.75e-05	0.000237	CcSEcCtD
Carvedilol—Hypersensitivity—Losartan—type 2 diabetes mellitus	1.74e-05	0.000236	CcSEcCtD
Carvedilol—Nausea—Valsartan—type 2 diabetes mellitus	1.73e-05	0.000235	CcSEcCtD
Carvedilol—Constipation—Ramipril—type 2 diabetes mellitus	1.73e-05	0.000235	CcSEcCtD
Carvedilol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	1.72e-05	0.000233	CcSEcCtD
Carvedilol—Nausea—Orlistat—type 2 diabetes mellitus	1.71e-05	0.000232	CcSEcCtD
Carvedilol—Asthenia—Losartan—type 2 diabetes mellitus	1.69e-05	0.00023	CcSEcCtD
Carvedilol—Vomiting—Metformin—type 2 diabetes mellitus	1.69e-05	0.000229	CcSEcCtD
Carvedilol—Rash—Metformin—type 2 diabetes mellitus	1.68e-05	0.000227	CcSEcCtD
Carvedilol—Dermatitis—Metformin—type 2 diabetes mellitus	1.68e-05	0.000227	CcSEcCtD
Carvedilol—Pruritus—Losartan—type 2 diabetes mellitus	1.67e-05	0.000226	CcSEcCtD
Carvedilol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	1.67e-05	0.000226	CcSEcCtD
Carvedilol—Headache—Metformin—type 2 diabetes mellitus	1.67e-05	0.000226	CcSEcCtD
Carvedilol—Dizziness—Irbesartan—type 2 diabetes mellitus	1.66e-05	0.000225	CcSEcCtD
Carvedilol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	1.66e-05	0.000224	CcSEcCtD
Carvedilol—Diarrhoea—Losartan—type 2 diabetes mellitus	1.62e-05	0.000219	CcSEcCtD
Carvedilol—Urticaria—Ramipril—type 2 diabetes mellitus	1.61e-05	0.000218	CcSEcCtD
Carvedilol—Abdominal pain—Ramipril—type 2 diabetes mellitus	1.6e-05	0.000217	CcSEcCtD
Carvedilol—Body temperature increased—Ramipril—type 2 diabetes mellitus	1.6e-05	0.000217	CcSEcCtD
Carvedilol—Vomiting—Irbesartan—type 2 diabetes mellitus	1.6e-05	0.000216	CcSEcCtD
Carvedilol—Rash—Irbesartan—type 2 diabetes mellitus	1.58e-05	0.000214	CcSEcCtD
Carvedilol—Dermatitis—Irbesartan—type 2 diabetes mellitus	1.58e-05	0.000214	CcSEcCtD
Carvedilol—Nausea—Metformin—type 2 diabetes mellitus	1.58e-05	0.000214	CcSEcCtD
Carvedilol—Headache—Irbesartan—type 2 diabetes mellitus	1.57e-05	0.000213	CcSEcCtD
Carvedilol—Dizziness—Losartan—type 2 diabetes mellitus	1.56e-05	0.000212	CcSEcCtD
Carvedilol—Vomiting—Losartan—type 2 diabetes mellitus	1.5e-05	0.000203	CcSEcCtD
Carvedilol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	1.49e-05	0.000202	CcSEcCtD
Carvedilol—Nausea—Irbesartan—type 2 diabetes mellitus	1.49e-05	0.000202	CcSEcCtD
Carvedilol—Rash—Losartan—type 2 diabetes mellitus	1.49e-05	0.000202	CcSEcCtD
Carvedilol—Dermatitis—Losartan—type 2 diabetes mellitus	1.49e-05	0.000202	CcSEcCtD
Carvedilol—Headache—Losartan—type 2 diabetes mellitus	1.48e-05	0.0002	CcSEcCtD
Carvedilol—Asthenia—Ramipril—type 2 diabetes mellitus	1.45e-05	0.000197	CcSEcCtD
Carvedilol—Pruritus—Ramipril—type 2 diabetes mellitus	1.43e-05	0.000194	CcSEcCtD
Carvedilol—Nausea—Losartan—type 2 diabetes mellitus	1.4e-05	0.00019	CcSEcCtD
Carvedilol—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.39e-05	0.000188	CcSEcCtD
Carvedilol—Dizziness—Ramipril—type 2 diabetes mellitus	1.34e-05	0.000181	CcSEcCtD
Carvedilol—Vomiting—Ramipril—type 2 diabetes mellitus	1.29e-05	0.000174	CcSEcCtD
Carvedilol—Rash—Ramipril—type 2 diabetes mellitus	1.28e-05	0.000173	CcSEcCtD
Carvedilol—Dermatitis—Ramipril—type 2 diabetes mellitus	1.28e-05	0.000173	CcSEcCtD
Carvedilol—Headache—Ramipril—type 2 diabetes mellitus	1.27e-05	0.000172	CcSEcCtD
Carvedilol—Nausea—Ramipril—type 2 diabetes mellitus	1.2e-05	0.000163	CcSEcCtD
Carvedilol—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.21e-07	8.92e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.19e-07	8.89e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.19e-07	8.89e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.19e-07	8.89e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	5.19e-07	8.88e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	5.18e-07	8.86e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	5.17e-07	8.84e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	5.12e-07	8.77e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.11e-07	8.75e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.11e-07	8.75e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	5.11e-07	8.74e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.09e-07	8.72e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	5.08e-07	8.7e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	5.08e-07	8.69e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	5.06e-07	8.67e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	5.05e-07	8.63e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	5.05e-07	8.63e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.03e-07	8.61e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.03e-07	8.61e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.03e-07	8.61e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.02e-07	8.6e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.01e-07	8.57e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	5e-07	8.56e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	5e-07	8.56e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.98e-07	8.53e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	4.98e-07	8.52e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	4.97e-07	8.51e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.94e-07	8.46e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.94e-07	8.45e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	4.93e-07	8.44e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.91e-07	8.41e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	4.91e-07	8.4e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.89e-07	8.38e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	4.89e-07	8.37e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.89e-07	8.37e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	4.87e-07	8.34e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.87e-07	8.34e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	4.87e-07	8.33e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	4.85e-07	8.3e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	4.84e-07	8.29e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	4.81e-07	8.23e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	4.81e-07	8.23e-06	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.81e-07	8.23e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.79e-07	8.2e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.79e-07	8.2e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	4.78e-07	8.19e-06	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.76e-07	8.15e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.76e-07	8.15e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.76e-07	8.14e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	4.75e-07	8.13e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.73e-07	8.1e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.73e-07	8.1e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.72e-07	8.08e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	4.71e-07	8.07e-06	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL6—type 2 diabetes mellitus	4.71e-07	8.06e-06	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.7e-07	8.05e-06	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL6—type 2 diabetes mellitus	4.7e-07	8.04e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.69e-07	8.03e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	4.67e-07	8e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	4.67e-07	8e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.66e-07	7.98e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	4.66e-07	7.97e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.65e-07	7.96e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.65e-07	7.96e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	4.64e-07	7.95e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.63e-07	7.93e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	4.63e-07	7.93e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.63e-07	7.92e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.63e-07	7.92e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	4.62e-07	7.91e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	4.61e-07	7.9e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	4.6e-07	7.88e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.6e-07	7.87e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	4.58e-07	7.85e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	4.57e-07	7.81e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	4.56e-07	7.8e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.55e-07	7.79e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.55e-07	7.79e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.54e-07	7.77e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.54e-07	7.77e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	4.52e-07	7.73e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.5e-07	7.7e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	4.48e-07	7.66e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.46e-07	7.63e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.45e-07	7.62e-06	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.45e-07	7.62e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	4.44e-07	7.6e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.44e-07	7.59e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	4.43e-07	7.59e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.42e-07	7.56e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.41e-07	7.55e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.41e-07	7.55e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.4e-07	7.54e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	4.4e-07	7.54e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	4.39e-07	7.51e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.38e-07	7.5e-06	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.38e-07	7.5e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	4.37e-07	7.48e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.37e-07	7.48e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.37e-07	7.47e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	4.37e-07	7.47e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.36e-07	7.46e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.36e-07	7.46e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.36e-07	7.46e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	4.35e-07	7.45e-06	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.35e-07	7.44e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.34e-07	7.43e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.34e-07	7.43e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	4.34e-07	7.42e-06	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.34e-07	7.42e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4.33e-07	7.41e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.33e-07	7.4e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.31e-07	7.38e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	4.3e-07	7.36e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	4.27e-07	7.31e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.27e-07	7.31e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	4.24e-07	7.25e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.22e-07	7.22e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.22e-07	7.22e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.21e-07	7.21e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.17e-07	7.13e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	4.16e-07	7.12e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.15e-07	7.1e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.12e-07	7.06e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	4.11e-07	7.04e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.1e-07	7.02e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.07e-07	6.97e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.06e-07	6.95e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.06e-07	6.94e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.06e-07	6.94e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.04e-07	6.92e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.04e-07	6.92e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.01e-07	6.86e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	3.99e-07	6.84e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.99e-07	6.83e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.99e-07	6.83e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.98e-07	6.81e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.98e-07	6.81e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	3.97e-07	6.8e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.95e-07	6.77e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.92e-07	6.7e-06	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.89e-07	6.66e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.85e-07	6.6e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	3.84e-07	6.57e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.83e-07	6.55e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.82e-07	6.54e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3.79e-07	6.49e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.79e-07	6.48e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	3.78e-07	6.47e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.76e-07	6.43e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.76e-07	6.43e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.75e-07	6.42e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.74e-07	6.4e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.74e-07	6.4e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.73e-07	6.38e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	3.72e-07	6.36e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	3.72e-07	6.36e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.71e-07	6.35e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.69e-07	6.32e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.68e-07	6.3e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.68e-07	6.29e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	3.67e-07	6.29e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.65e-07	6.24e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.64e-07	6.23e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.64e-07	6.23e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.63e-07	6.21e-06	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.61e-07	6.19e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.6e-07	6.17e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.6e-07	6.17e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.58e-07	6.13e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.58e-07	6.13e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.56e-07	6.09e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.56e-07	6.09e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.53e-07	6.05e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.49e-07	5.97e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.49e-07	5.97e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.49e-07	5.97e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	3.44e-07	5.88e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.43e-07	5.88e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.42e-07	5.86e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	3.41e-07	5.83e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.38e-07	5.79e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.38e-07	5.78e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.37e-07	5.76e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	3.36e-07	5.75e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.35e-07	5.73e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.35e-07	5.73e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.34e-07	5.71e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.31e-07	5.67e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.29e-07	5.63e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.29e-07	5.63e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.28e-07	5.62e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.27e-07	5.6e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	3.26e-07	5.58e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	3.26e-07	5.58e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.25e-07	5.57e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.24e-07	5.54e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.21e-07	5.5e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.19e-07	5.46e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.18e-07	5.44e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	3.12e-07	5.34e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.08e-07	5.27e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	3.07e-07	5.25e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.04e-07	5.2e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.02e-07	5.17e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.01e-07	5.15e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3e-07	5.14e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.98e-07	5.1e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.94e-07	5.04e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.93e-07	5.01e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.91e-07	4.98e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.88e-07	4.93e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.87e-07	4.91e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	2.86e-07	4.89e-06	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	2.85e-07	4.88e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.84e-07	4.85e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.83e-07	4.85e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.8e-07	4.79e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.79e-07	4.77e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.78e-07	4.77e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.78e-07	4.77e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	2.77e-07	4.74e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.74e-07	4.68e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.74e-07	4.68e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	2.59e-07	4.43e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.58e-07	4.41e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.56e-07	4.37e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.55e-07	4.36e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	2.55e-07	4.36e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.52e-07	4.32e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.5e-07	4.28e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.45e-07	4.19e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.39e-07	4.09e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.35e-07	4.02e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	2.32e-07	3.97e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.26e-07	3.87e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.25e-07	3.85e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.15e-07	3.68e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.15e-07	3.68e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	2.13e-07	3.64e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.1e-07	3.6e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.09e-07	3.57e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	2.01e-07	3.44e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.97e-07	3.36e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.94e-07	3.32e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.6e-07	2.74e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.51e-07	2.59e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.5e-07	2.56e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.28e-07	2.19e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	9.88e-08	1.69e-06	CbGpPWpGaD
